🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Fatty Liver

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease NCT07051863n/a1 site📍 Lugano Fondazione Epatocentro Ticino Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD NCT06704321NA1 site📍 Québec Valbiotis · Tests: TOTUM-448, Placebo Global Research Initiative for Patients Screening on MASH NCT05651724n/a13 sites📍 Brussels📍 Antwerp📍 Prague Julius Clinical NAFLD Clinical Care Pathway NCT06671886NA1 site📍 Houston VA Office of Research and Development · Tests: E-trigger The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States NCT05832229Phase 213 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Institute of Diabetes and Digestive and Kidney Dis… · Tests: Rosuvastatin Rezdiffra Pregnancy and Lactation Registry NCT07541469n/a1 site📍 West Conshohocken Madrigal Pharmaceuticals, Inc. · Tests: Rezdiffra An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) NCT06569524Phase 253 sites📍 Lu'an📍 Lu'an📍 Beijing Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Phar… · Tests: TQA2225/AP025 or TQA2225/AP025 Placebo 25mg, TQA2225/AP025 or TQA2225/AP025 Placebo 50mg Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants NCT07512427Phase 1, Phase 21 site📍 Miami OPKO Health, Inc. · Tests: OPK-88006, Placebo Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease NCT05332613NA1 site📍 New York Weill Medical College of Cornell University · Tests: TRE plus SOC, SOC, TRE Fructose and Liver Diseases in Youth: Help Them FLY NCT05528471NA1 site📍 Edmonton University of Alberta · Tests: Dietary intervention A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH) NCT07732400Phase 1, Phase 23 sites📍 Chandler📍 Lady Lake📍 Auckland Kriya Therapeutics, Inc. · Tests: VV-14303 Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease NCT04141592n/a1 site📍 London Queen Mary University of London · Tests: Bariatric Surgery Androgens and NAFLD Longitudinal Cohort Study NCT06124261n/a2 sites📍 San Francisco📍 Durham University of California, San Francisco Prognostic Significance of Fatty Liver Disease in Bariatric Patients NCT03535142NA1 site📍 Esbjerg Esbjerg Hospital - University Hospital of Southern Denmark · Tests: Bariatric surgery Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals NCT05890365n/a1 site📍 Herlev Steno Diabetes Center Copenhagen A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH NCT06419374Phase 3330 sites📍 Birmingham📍 Homewood📍 Chandler Hoffmann-La Roche · Tests: Pegozafermin, Placebo Pyramidal Versus Continuous Training Effects on Fatty Liver NCT06803108NA1 site📍 Giza Cairo University · Tests: pyramidal activity program, aerobic activity program Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD NCT05644717Phase 41 site📍 Peshawar Getz Pharma · Tests: Ertugliflozin 5 mg, 15mg Longitudinal Observational Study Of Chinese With NAFLD/NASH NCT03151473n/a1 site📍 Hong Kong Humanity and Health Research Centre Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) NCT04634643n/a1 site📍 New Haven Yale University · Tests: Usual diet and physical activity Fasted Exercise Training in Type 1 Diabetes (FED-T1D) NCT06748963NA1 site📍 Edmonton University of Alberta · Tests: Fasted Exercise, Postprandial Exercise Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease NCT07058155Phase 41 site📍 Cleveland The Cleveland Clinic · Tests: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect), … Short-term Fat Overfeeding on the Effects of Liver Metabolism NCT05962190NA1 site📍 Oxford University of Oxford · Tests: Diet Identification of Liver Fibrosis Biomarkers NCT06819917n/a2 sites📍 Copenhagen📍 Mainz Roche Diagnostics GmbH · Tests: Identification of liver fibrosis biomarkers A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment NCT07807059Phase 11 site📍 Chengdu Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-4729 Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis NCT05884723NA1 site📍 London Anton Skaro · Tests: Ketogenic Diet Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease NCT06879236n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy